SUMITOMO PHARMA CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 403 JPY | -1.47% |
|
+6.05% | -13.52% |
| Apr. 22 | Lull in Geopolitical Tensions Lifts Asian Stock Markets | MT |
| Apr. 17 | Jefferies Adjusts Sumitomo Pharma’s Price Target to 420 Yen From 520 Yen, Keeps at Hold | MT |
Chart calendar Sumitomo Pharma Co., Ltd.
a15ff194559.Smn2k-_tIH6MZwvUmatbp8qj1oZ-iPsUHCfSiTnC6zk.LFyBqteaQRv6V02H9Jka7IvsnM0MzLdCK22jvX6bhQFyPZ_VtbwSO8ZSbA~68b91a6ec4e5ccab98162ab37c5b5513
Upcoming events on Sumitomo Pharma Co., Ltd.
Past events on Sumitomo Pharma Co., Ltd.
| 2024-01-30 | Q3 2023 Earnings Release |
| 2023-10-31 12:30 am | Q2 2023 Earnings Release |
| 2023-10-31 12:00 am | Q2 2023 Earnings Call |
| 2023-07-30 | Q1 2023 Earnings Call |
| 2023-07-30 | Q1 2023 Earnings Release |
| 2023-05-15 12:00 am | Q4 2022 Earnings Call |
| 2023-05-14 | Q4 2022 Earnings Release |
| 2023-04-28 12:00 am | Analyst Meeting - Business Plan (FY2023-FY2027) |
| 2023-03-29 | Ex-dividend day for final dividend |
| 2023-01-31 01:30 am | Q3 2022 Earnings Release |
| 2023-01-30 | Q3 2022 Earnings Call |
| 2022-12-12 08:00 pm | Investor Meeting - ESG |
| 2022-10-31 | Interim 2022 Earnings Call |
| 2022-10-30 | Interim 2022 Earnings Release |
| 2022-09-28 | Ex-dividend day for dividende intermédiaire |
| 2022-07-28 | Q1 2022 Earnings Call |
| 2022-07-28 | Q1 2022 Earnings Release |
| 2022-06-22 09:00 pm | Annual General Meeting |
| 2022-05-15 | FY 2021 Earnings Call |
| 2022-05-12 | FY 2021 Earnings Release |
Past dividends on Sumitomo Pharma Co., Ltd.
| 2023-03-29 | Final Payment 7 JPY |
| 2022-09-28 | Interim Payment 14 JPY |
| 2022-03-29 | Final Payment 14 JPY |
| 2021-09-28 | Interim Payment 14 JPY |
| 2021-03-29 | Final Payment 14 JPY |
| 2020-09-28 | Interim Payment 14 JPY |
| 2020-03-29 | Final Payment 14 JPY |
| 2019-09-26 | Interim Payment 14 JPY |
| 2019-03-26 | Bonus Payment 2 JPY |
| 2019-03-26 | Final Payment 17 JPY |
Annual results
| Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 459 267 461 882 -0.57% | 482 732 478 703 0.84% | 515 952 519 600 -0.7% | 560 035 561 500 -0.26% | 555 544 556 119 -0.1% | 316 260 |
|
EBITDA Million JPY | Released Forecast Spread | 71 860 69 130 3.95% | 100 604 97 109 3.6% | 93 897 82 643 13.62% | 98 582 94 122 4.74% | 57 627 39 498 45.9% | -165 073 |
|
EBIT Million JPY | Released Forecast Spread | 57 884 55 766 3.8% | 83 239 78 567 5.95% | 71 224 55 794 27.65% | 60 234 57 825 4.17% | -76 979 -25 067 -207.09% | -200 985 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 65 046 59 479 9.36% | 83 947 81 345 3.2% | 77 851 47 039 65.5% | 82 961 62 212 33.35% | -47 920 -13 605 -252.22% | -197 567 |
|
Net income Million JPY | Released Forecast Spread | 48 627 40 852 19.03% | 40 753 32 827 24.14% | 56 219 30 811 82.46% | 56 413 45 390 24.29% | -74 512 -34 704 -114.71% | -198 180 |
|
EPS JPY | Released Forecast Spread | 122 102 20.16% | 103 81,9 25.22% | 142 75,8 86.64% | 142 114 24.3% | -188 -79,8 -135.01% | -499 |
| Announcement Date | 10/05/19 | 13/05/20 | 12/05/21 | 13/05/22 | 15/05/23 | - |
Quarterly results
| Fiscal Period | March | 2020 S1 | 2020 S2 | 2021 S1 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 S1 | 2026 S1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 230 603 230 184 0.18% | 252 129 251 014 0.44% | 261 498 251 000 4.18% | 293 730 301 700 -2.64% | 138 342 140 367 -1.44% | 127 963 | 159 876 143 367 11.52% | 159 400 136 300 16.95% | 319 300 281 000 13.63% | 140 976 | 75 700 94 100 -19.55% | 76 942 92 800 -17.09% | 152 642 191 650 -20.35% | 82 386 91 700 -10.16% | 79 948 | 81 269 | 166 420 | 177 456 | |
|
EBITDA Million JPY | Released Forecast Spread | -21 646 5 600 -486.54% | ||||||||||||||||||
|
EBIT Million JPY | Released Forecast Spread | 66 835 59 840 11.69% | 16 404 14 137 16.04% | 47 539 29 200 62.8% | 47 572 49 300 -3.51% | 10 656 9 633 10.62% | 2 006 -600 434.33% | 14 614 16 133 -9.42% | -43 500 -2 100 -1971.43% | -28 900 29 500 -197.97% | 11 138 | -51 600 -13 700 -276.64% | -34 898 -5 800 -501.69% | -86 498 -32 500 -166.15% | -31 247 -10 600 -194.78% | -51 031 | -18 664 | -36 422 | -9 217 | |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 64 147 57 325 11.9% | 19 800 20 786 -4.74% | 43 654 29 100 50.01% | 49 266 52 000 -5.26% | 16 317 11 846 37.74% | 17 378 -2 406 822.43% | 46 610 13 433 246.99% | -25 610 75,0 -34246.67% | 21 000 29 500 -28.81% | -18 842 | -31 100 -13 300 -133.83% | -25 027 -22 000 -13.76% | -56 127 -23 900 -134.84% | -49 064 -18 000 -172.58% | -75 455 | -18 754 | -36 602 | -9 397 | |
|
Net income Million JPY | Released Forecast Spread | 30 330 21 020 44.29% | 10 423 | 37 297 27 300 36.62% | 36 450 33 800 7.84% | 9 909 11 946 -17.05% | 10 054 -906 1210.33% | 31 108 9 583 224.63% | -38 400 2 475 -1651.52% | -7 300 21 300 -134.27% | -11 219 | -38 900 -6 800 -472.06% | -28 841 -27 000 -6.82% | -67 741 -14 800 -357.71% | -49 967 -15 200 -228.73% | -64 419 | -14 065 | -27 452 | -7 048 | |
|
EPS JPY | Released Forecast Spread | 76,3 60,4 26.39% | 93,9 68,7 36.65% | 91,8 85,1 7.81% | 24,9 30,1 -17.14% | 25,3 6,00 321.67% | 78,3 24,1 224.9% | -96,6 6,20 -1658.55% | -18,3 53,6 -134.2% | -28,2 | -141 -81,4 -73.3% | -97,8 -17,1 -472.05% | -72,7 -43,2 -68.46% | -171 -37,3 -357.13% | -126 -39,9 -215.09% | -266 | -35,4 | -69,1 | -17,7 | |
| Announcement Date | 28/10/19 | 13/05/20 | 28/10/20 | 27/10/21 | 31/01/22 | 13/05/22 | 29/07/22 | 31/10/22 | 31/10/22 | 31/01/23 | 15/05/23 | 31/07/23 | 31/10/23 | 31/10/23 | 31/01/24 | - | - | - | - |
More events
Past sector events for Sumitomo Pharma Co., Ltd.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4506 Stock
- Calendar Sumitomo Pharma Co., Ltd.
